BPC-157 Dosing Protocol
BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from human gastric juice proteins. Research studies have explored dosing strategies across subcutaneous, intramuscular, and oral routes. This protocol compiles findings from published literature to guide research applications.
Key Points
Step-by-Step Guide
Determine Research Objective
Identify whether the study targets gut healing, tendon repair, joint recovery, or systemic protection. The objective influences dose selection and administration route.
Select Administration Route
Subcutaneous injection near the target area is most common. Oral administration shows efficacy for GI studies. Intramuscular injection is used for localized muscle or tendon work.
Calculate Dosage
Research dosages range from 200-800 mcg/day. Most studies use 250-500 mcg once or twice daily. Weight-based dosing from animal studies translates to approximately 2.5-10 mcg/kg human-equivalent.
Establish Timing
Administer on an empty stomach for subcutaneous injections, ideally 30 minutes before meals. Split dosing (250 mcg morning + 250 mcg evening) may provide more consistent levels.
Set Study Duration
Typical cycles run 4-8 weeks. Acute injury studies may use 2-4 weeks. Chronic conditions may extend to 8-12 weeks with periodic assessments.
Monitor and Adjust
Track biomarkers relevant to the objective. Assess tissue healing progress at regular intervals. Adjust dosing based on response within established research ranges.
Warnings & Precautions
- !BPC-157 is not approved by the FDA for human use.
- !All dosing information is derived from preclinical and early clinical literature.
- !Consult institutional review protocols before any peptide research.
- !Store reconstituted BPC-157 at 2-8°C and use within 28 days.
Frequently Asked Questions
What is the most common BPC-157 research dosage?
The most cited dosage is 250-500 mcg/day subcutaneously. Some studies use weight-based dosing at approximately 5 mcg/kg body weight.
How long do BPC-157 research protocols typically last?
Most studies run 4-8 weeks. Shorter 2-4 week protocols are used for acute injury models, while chronic conditions may warrant 8-12 weeks.
Can BPC-157 be taken orally?
Yes. Oral BPC-157 has shown efficacy in GI studies due to its unusual stability in gastric acid, making oral delivery viable for gut-related research.